This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Pharmacokinetics of Enoxaparin in Intensive Care P...
Clinical trial

Pharmacokinetics of Enoxaparin in Intensive Care Patients

Read time: 1 mins
Last updated:18th Mar 2014

To evaluate the pharmacokinetics of the thromboprophylactic agent enoxaparin in critically ill patients by comparing plasma anti-factor Xa activity when enoxaparin is administered either as a continuous intravenous infusion or subcutaneous bolus once daily.

To investigate possible ongoing coagulation by coagulation markers during antithrombotic therapy with standard doses of enoxaparin

Category Value
Study start date 2014-03-18

View full details